These natural compounds play a key role in regulating your bodys operations, making them vital to your wellness journey
Its important for patients to understand that off-label uses are based on the doctors judgment, and they should discuss the potential benefits and risks associated with such uses
Understanding your genetic predispositions in appetite and incretin pathways can support a more informed conversation with your gastroenterologist or primary care provider about whether compounded GLP-1 therapy (semaglutide, tirzepatide, or microdose protocols) is appropriate for your gastroparesis status
Sakakeeny L, Roubenoff R, Obin M, Fontes JD, Benjamin EJ, Bujanover Y, et al
The idea that semaglutide may promote a more anti-inflammatory, pro-regenerative progenitor cell profile could help explain some of the cardiovascular risk reduction were observing in trials
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, known for its appetite-suppressing effects
